Startup

Gadget Ghupshup

Local Legends

Tech takes

Brokerage

Top Shows

stock in news cipla havells hindustan zinc shriram

market outlook today nifty banknifty support levels

davos zelensky trump meeting us markets rally

Stricter traffic rules aim to cut accidents, fatalities across India

Trump praises PM Modi at Davos 2026, hints at strong India-US trade deal

Home

Personal Finance

India

Economy

Tech

Auto

Markets

Jobs

Indian Railways

World

Videos

Photos

https://www.zeebiz.com/market-news/video-gallery-biocon-biologics-wholly-owned-subsidiary-share-swap-385091

Biocon has announced a strategic move to make Biocon Biologics its wholly owned subsidiary through a share swap arrangement. By acquiring minority stakes, Biocon aims to simplify its corporate structure, strengthen financial flexibility, and enhance long-term value creation. In an exclusive interaction with Anil Singhvi, Biocon Biologics MD &amp; CEO Shreehas Tambe highlighted that full ownership will accelerate decision-making, improve capital allocation, and create a unified biologics platform. The share swap structure minimizes cash outflow while strengthening the balance sheet. The company also outlined plans to keep fundraising options open based on future requirements, while prioritizing debt repayment in the combined entity. This restructuring is expected to improve operational efficiency and support global expansion in biosimilars. Overall, the move reinforces Biocon’s long-term vision to build a strong, scalable global biologics business with improved financial stability.

Full ownership of biocon biologics to boost efficiency and expansion

<p>Biocon has announced a strategic move to make Biocon Biologics its wholly owned subsidiary through a share swap arrangement. By acquiring minority stakes, Biocon aims to simplify its corporate structure, strengthen financial flexibility, and enhance long-term value creation. In an exclusive interaction with Anil Singhvi, Biocon Biologics MD &amp; CEO Shreehas Tambe highlighted that full ownership will accelerate decision-making, improve capital allocation, and create a unified biologics platform. The share swap structure minimizes cash outflow while strengthening the balance sheet. The company also outlined plans to keep fundraising options open based on future requirements, while prioritizing debt repayment in the combined entity. This restructuring is expected to improve operational efficiency and support global expansion in biosimilars. Overall, the move reinforces Biocon’s long-term vision to build a strong, scalable global biologics business with improved financial stability.</p>


Full ownership of biocon biologics to boost efficiency and expansion

market outlook today nifty banknifty support levels

davos zelensky trump meeting us markets rally

Stricter traffic rules aim to cut accidents, fatalities across India

Recommended Videos

stock in news cipla havells hindustan zinc shriram

market outlook today nifty banknifty support levels

davos zelensky trump meeting us markets rally

other shows